まとめ
強力な腫瘍促進剤であるPhorbol-12-myristate-13-acetate (PMA) は,様々な細胞機能を変化させ,がんと闘う免疫システムの能力に影響を与える可能性があります. この研究では,PMAがマクロファージおよび腫瘍に対する自然殺傷細胞活動に及ぼす影響を調査しています.
科学分野:
- 腫瘍学 腫瘍学
- 免疫学 免疫学とは
- 細胞生物学 細胞生物学
背景:
- 化学カルシノゲネシスには,発症と増殖の段階があり,ホルボル-12-ミリスタート-13-アセテート (PMA) は強力な腫瘍増殖剤である.
- PMAのようなホルボールのエステルは,多様な真核細胞に重大な変化を起こし,分化,代謝,遺伝子発現に影響を与えます.
- 抗腫瘍抵抗に不可欠な宿主免疫エフェクタシステムに対する腫瘍プロモーターの影響は,ほとんど不明のままである.
研究 の 目的:
- マクロファージと自然殺虫細胞 (NK) によって媒介される自発的な in vitro 細胞毒性に対する PMA の影響を調査する.
- ネズミの線維肉腫に対するインビボ耐性に対するPMAの影響を決定する.これは,単核ファゴサイトのような免疫効果細胞に依存するプロセスである.
主な方法:
- マクロファージとNK細胞の細胞毒性活動に対するPMAのインビトロ評価.
- PMAの存在下での腫瘍耐性を評価するインビヴォ研究で,単核ファゴサイト機能に焦点を当てた.
主要な成果:
- PMAは,代謝とDNA合成を含む様々な細胞のプロセスを変化させることが判明しました.
- この研究では,抗腫瘍反応に関与する免疫細胞に対するPMAの影響を特に調べました.
- 自発的な細胞毒性および腫瘍抵抗に対する効果は,免疫効果細胞との関係で分析されました.
結論:
- PMAのような腫瘍プロモーターは,正常細胞と悪性細胞の両方で,変異したフェノタイプの発現に影響を与えることができます.
- PMAが宿主の免疫監視と抗腫瘍耐性メカニズムにどのように影響するかを完全に理解するために,さらなる研究が必要です.
さらに関連する動画
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
関連する概念動画
Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
